Christopher Hill's most recent trade in Core Laboratories N.V. was a trade of 68,800 Performance Shares done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 68,800 | 68,800 | - | - | Performance Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 23,607 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 23,607 | 95,656 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.31 per share. | 31 Dec 2024 | 14,719 | 80,937 (0%) | 0% | 17.3 | 254,786 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 07 Jul 2023 | 17,076 | 510,788 (1%) | 0% | 0.9 | 15,881 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 28 Mar 2023 | 135,200 | 527,864 (1%) | 0% | 1.0 | 128,440 | Common Stock |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 52,718 | 52,718 | - | - | Performance Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 31,688 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 31,688 | 62,642 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.27 per share. | 31 Dec 2022 | 12,470 | 50,172 (0%) | 0% | 20.3 | 252,767 | Common Shares |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2022 | 163,399 | 163,399 | - | - | Stock Option (Right to Buy) | |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 1.19 per share. | 08 Jul 2022 | 163,399 | 392,664 (0%) | 0% | 1.2 | 194,445 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 11 Mar 2022 | 46,230 | 187,173 (0%) | 0% | 1.2 | 55,014 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 11 Mar 2022 | 26,023 | 225,698 (0%) | 0% | 1.2 | 31,228 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 11 Mar 2022 | 12,502 | 199,675 (0%) | 0% | 1.2 | 14,940 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 11 Mar 2022 | 7,701 | 138,556 (0%) | 0% | 1.2 | 9,087 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 11 Mar 2022 | 3,567 | 229,265 (0%) | 0% | 1.2 | 4,298 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 11 Mar 2022 | 2,387 | 140,943 (0%) | 0% | 1.2 | 2,829 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 11 Mar 2022 | 1,590 | 130,855 (0%) | 0% | 1.2 | 1,868 | Common Stock |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 43,236 | 43,236 | - | - | Performance Shares | |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 02 Feb 2022 | 1,019 | 129,265 (0%) | 0% | 2.1 | 2,111 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 02 Nov 2021 | 1,005 | 130,284 (0%) | 0% | 2.5 | 2,513 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 2.25 per share. | 18 Oct 2021 | 33,334 | 131,289 (0%) | 0% | 2.3 | 75,002 | Common Stock |
| Synchronoss Technologies Inc | Christopher Hill | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 33,334 | 33,334 | - | - | Stock Option (Right to Buy) | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 33,950 | 33,950 | - | - | Performance Shares |